NEW MEDICINES FOR TOPIC USE BASED ON SULFATED HYALURONIC ACID AS ACTIVATING OR INHIBITING AGENT OF THE CYTOKINE ACTIVITY

摘要

The object of the present invention relates to sulfated hyaluronic acid (HAS) for topical use in the prevention and/or treatment of skin pathologies associated with damage to the endothelium and/or the wall of blood vessels, in the treatment of clots of fibrin and thrombi which are formed at the skin level; as a skin absorption promoter of pharmacologically and/or biologically active agents and in the prevention and/or treatment of Herpes Simplex labialis and Herpes genitalis, the virus of Vesicular Stomatitis and Cytomegalovirus.